Recently, the American Diabetes Association (ADA) in conjunction with the European Association for the Study of Diabetes (EASD) convened a panel to overhaul their approach toward type 2 diabetes in adults. The panel suggested that organizations helping type 2 diabetes patients should have an additional focus on lifestyle management and diabetes self-management with education and support. Nigel Dessau, the president & COO at Wellsmith feels that the recommendations made by the associations raise the most critical factors for successful type 2 diabetes management, and his company is uniquely positioned to do so in the healthcare space.
Today, Wellsmith helps adults with type 2 diabetes to control their chronic condition as well as discover critical moments in their day that can affect their health.
Helping manage blood sugar is an important part of what makes Wellsmith unique. A trial participant habitually ate a morning honey bun containing lots of sugar and carbohydrates. Once he started using the Wellsmith platform, he could see his blood sugar levels daily, weekly, and monthly. He then adjusted his breakfast food and quickly realized the positive impact. He could better follow his doctor-prescribed care plan via the Wellsmith platform to maintain his sugar levels, which helped him lead a healthier lifestyle.
Wellsmith is launching the second version of its product with Cone Health in the first half of 2019. “The plan for this year is to keep building our relationship with the existing customers while for next year, we will add more providers and healthcare customers and roll out the product broadly,” says Dessau.
Besides type 2 diabetes, Wellsmith has conducted trials for other chronic diseases such as chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), and hypertension. Wellsmith is making efforts to manage multiple chronic disease comorbidities that will allow consumers to manage their chronic diseases through a single app.